Bryan Kim

Bryan Kim is the EVP of Global Specialties at Stada Group. Bryan has over 20 years of experience in the pharmaceutical and healthcare industries.

Bryan started their career as a Research Analyst at the Center for Media and Public Affairs. Bryan then worked as a Business Development Manager at Intel Corporation. In 2003, they joined Booz & Company as a Senior Associate.

In 2008, Bryan joined Pfizer as the US Marketing Director for Neuroscience. Bryan then moved to Boehringer Ingelheim in 2012, where they held the title of Executive Director/Regional Management for China, Korea, SE Asia, and India.

Most recently, Bryan was the Vice President of Business Development at Samsung Bioepis from 2016 to 2021. Bryan has been with Stada Group since February 2021.

Bryan Kim graduated with a MBA from Yale School of Management and a BA in Public Health/Pre-med from The Johns Hopkins University. Bryan also has certification from Harvard Law School Executive Education in Master Course on Negotiation and Six Sigma Green Belt.

Their manager is Peter Goldschmidt, Chairman & CEO. Some of their coworkers include Christoph Dengler - EVP, Global Legal, Miguel Pagan Fernandez - CTO, and Carsten Cron - EVP, Emerging Markets.